We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Nanopore Method Detects Single Influenza Virus at Single Particle Level

By LabMedica International staff writers
Posted on 03 Dec 2018
A team of Japanese researchers has introduced a novel sensor concept capable of discriminating various types of influenza virus in a label-free fashion by their distinct particle properties.

Rapid diagnosis of influenza infection before onset of symptoms would improve health care by reducing risk for serious complications as well as by preventing infectious disease outbreaks. More...
Sensor sensitivity and selectivity are critical to accomplishing this goal, as the number of virus particles is quite small at the early stage of infection.

To overcome the low particle number problem, investigators at Osaka University (Japan) developed a nanopore device with electroosmotic flow (liquid motion induced by an electric current across the nanopore) properties that ensured that the pore channel would block the passage of non-virus particles. The nanopores were designed to have low thickness-to-diameter aspect-ratio structure so as to render additional sensitivity to the particle shape and surface charges. This provided resistive pulses holding a complex set of information concerning not only the nanoparticle volume but multiple physical properties of the intact viral particles.

To evaluate the information set, the investigators employed machine-learning-driven pattern-analysis of the electrical signatures. This allowed for rapid detection and simultaneous subtype differentiation of virus particles with an ultimate sensitivity of single-particle discriminations. Results demonstrated the ability to identify allotypes with 68% accuracy at the single-virus level.

"We used machine-learning analysis of the electrical signatures of the virions," said contributing author Dr. Makusu Tsutsui, associate professor of scientific and industrial research at Osaka University. "Using this artificial intelligence approach to signal analysis, our method can recognize a slight current waveform difference, which cannot be discerned by human eyes. This enables high-precision identification of viruses."

"Our testing revealed that this new sensor may be suitable for use in a viral test kit that is both quick and simple," said first author Akihide Arima, a researcher in the chemistry department at Osaka University. "Importantly, use of this sensor does not require specialized human expertise, so it can readily be applied as a point-of-care screening approach by a wide variety of healthcare personnel."

The nanopore technique for detecting influenza virus was described in the November 2, 2018, online edition of the journal Scientific Reports.

Related Links:
Osaka University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.